Novartis
ARZERRA
Manufacturer:
Novartis
Name:
ARZERRA
HCPCS Code Descriptor:
Injection, ofatumumab, 10 mg
Category:
J Code
HCPCS:
J9302
NDC(s):
00078-0669-13, 00078-0669-61, 00078-0690-61
Primary Type:
Oncology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
ARZERRA is an Oncology drug manufactured by Novartis and administered via the Intravenous route of administration. The J Code: J9302 is aligned to the drug ARZERRA.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/11
HCPCS Effective Date:
1/1/11
HCPCS Short Description:
Ofatumumab injection
Billing and Coding Guide:
Not Found
Patient Assistance:
Not Found
